AI assistant
PFIZER INC — Director's Dealing 2012
Feb 28, 2012
29831_dirs_2012-02-27_2a285d7b-c862-4fd3-98ca-d1e243eabd9a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2012-02-23
Reporting Person: SIMMONS DAVID S (Business Unit President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-02-23 | Common Stock | A | 32988.0000 | $0.0000 | Acquired | 170745.0000 | Direct |
| 2012-02-24 | Common Stock | A | 16618.0000 | $0.0000 | Acquired | 187363.0000 | Direct |
| 2012-02-24 | Common Stock | F | 7483.0000 | $21.1800 | Disposed | 179880.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-02-23 | Stock Appreciation Rights | $21.0300 | A | 169903.0000 | Acquired | 2017-02-23 | Common Stock (169903.0000) | Direct |
| 2012-02-23 | Stock Appreciation Rights | $21.0300 | A | 144033.0000 | Acquired | 2019-02-23 | Common Stock (144033.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2365.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
F2: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
F3: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
F4: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F5: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.